[FOLFIRINOX after resection of pancreatic cancer sets new standards-systemic therapy providing an impulse for local treatment in resectable pancreatic cancer]

Strahlenther Onkol. 2019 Jun;195(6):570-572. doi: 10.1007/s00066-019-01449-2.

[Article in German]

Authors

Sabine Semrau¹, Dorota Lubgan²

Affiliations

¹ Strahlenklinik Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Universitätsstraße 27, 91054, Erlangen, Deutschland. sabine.semrau@uk-erlangen.de.
² Strahlenklinik Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Universitätsstraße 27, 91054, Erlangen, Deutschland.

PMID: 30847534
DOI: 10.1007/s00066-019-01449-2

No abstract available

Publication types

Comment

MeSH terms

Antineoplastic Combined Chemotherapy Protocols
Deoxycytidine / analogs & derivatives
Fluorouracil
Gemcitabine
Humans
Leucovorin
Pancreatic Neoplasms*

Substances

Deoxycytidine
Leucovorin
Fluorouracil
Gemcitabine